Overexpression of G protein - Coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein - Coupled and platelet-derived growth factor receptors

Circulation

Volumn 102, Issue 7, 2000, Pages 793-799

  Peppel, Karsten ^a   Jacobson, Anne ^a   Huang, Xuewei ^a   Murray, John P ^a   Oppermann, Martin ^b   Freedman, Neil J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cells; Muscle; Receptors; Signal transduction; Smooth

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; VIRUS VECTOR;

ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MITOGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VIRUS RECOMBINANT;

EID: 0033869812     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.7.793     Document Type: Article

References (26)

1. The molecular bases of restenosis
2. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: A five year prospective study
3. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses
4. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
5. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model
6. Prevention in intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan
7. 2, and specific receptor antagonists on vascular smooth muscle cell proliferation
8. Phosphorylation and desensitization of human endothelin A and B receptors: Evidence for G protein-coupled receptor kinase specificity
9. G protein-coupled receptor kinases
10. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine
11. The smooth muscle cell in culture
12. 1-adrenergic receptor: Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase
13. Potentiation of β-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes
14. Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases
15. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer
16. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts
17. Signal transduction via platelet-derived growth factor receptors
18. 3H]thymidine techniques to measure cell proliferation
19. EGF is incomplete mitogen in porcine aortic smooth muscle cells: DNA synthesis without cell division
20. A new family of regulators of G-protein-coupled receptors?
21. Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: Role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase
22. Effect of cellular expression of pleckstrin homology domains on G(i)-coupled receptor signaling
23. Adenoviral-mediated inhibition of Gβγ signaling limits the hyperplastic response in experimental vein grafts
24. Synergistic activation of a G protein-coupled receptor kinase by G protein βγ subunits and mastoparan or related peptides
25. Serine phosphorylation of the ligand-activated β-platelet derived growth factor receptor by casein kinase I-γ2 inhibits the receptor's autophosphorylating activity
26. Cell cycle progression: New therapeutic target for vascular proliferative disease